A lawsuit claims GoodRx mislead users about its data sharing practices that allowed Meta’s Facebook and Google to “intercept” personal and health data with no user consent. Named as defendants in suit are Meta, Google, Criteo and GoodRx.
The lawsuit, filed in the U.S. District Court of Northern California, asserts GoodRx, a telehealth and prescription drug discount provider, allowed Meta, Google, and Criteo to intercept consumer data and use it for digital marketing purposes. Last week, GoodRx was hit with a $1.5 million fine by the Federal Trade Commission for related data-sharing violations.
Consumers had no way of knowing that GoodRx was intercepting their private health data when interacting with the GoodRx Platform, according to the lawsuit filed on Feb. 2. The lawsuit argued, the GoodRx software collected that data “inconspicuously in the background.”
“This conduct is all the more egregious given the nature of the information entered into the GoodRx Platform, e.g., personally identifiable information, requests for prescriptions, and identifiable medical information, among other things,” said lawyers representing the plaintiff.
GoodRx, in response to the FTC action, said in a statement it was wrongly accused. It argued the recent action by the Feds focused on “an old issue that was proactively addressed almost three years ago, before the FTC inquiry began.”
“We do not agree with the FTC’s allegations and we admit no wrongdoing,” GoodRx leadership said in a statement. “Almost three years ago… we proactively made updates consistent with our commitment to being at the